Table 1.
Fibres from normal mice (α-MHC) | Fibres from PTU-treated mice (β-MHC) | |||
---|---|---|---|---|
α-MHC(cTnI) | α-MHC(ssTnI) | β-MHC(cTnI) | β-MHC(ssTnI) | |
ktr | 17.0 ± 0.67 | 17.0 ± 0.41 | 8.04 ± 0.17a | 8.87 ± 0.24b,c |
gapp | 5.02 ± 0.54 | 5.12 ± 0.35 | 1.73 ± 0.12a | 2.06 ± 0.08b,c |
fapp | 11.9 ± 0.75 | 11.9 ± 0.59 | 6.32 ± 0.23a | 6.72 ± 0.26c |
Tension cost | 7.58 ± 0.32 | 7.16 ± 0.19 | 2.99 ± 0.12a | 3.54 ± 0.10b,c |
c | 44.7 ± 2.98 | 43.1 ± 2.40 | 19.8 ± 0.77a | 22.0 ± 1.18c |
The rate constant of tension redevelopment, ktr (s−1), was determined based on a rapid slack/restretch protocol, and is reported here at maximal Ca2+ activation. The intercept of the exponential trend of ktr vs. activation level (Fig. 6) was used to determine gapp (s−1). fapp (s−1) was determined by taking the difference of ktr and gapp, since at max activation ktr≈fapp+gapp (Brenner & Eisenberg, 1986). Tension cost (pmol mN−1 mm−1 s−1) is reported as the slope of the regression from the relationship between tension and ATPase activity. c (s−1) is the model-predicted rate constant of XB detachment, and correlates with tension cost. Values are means ± SEM. Number of determinants is at least 10 for each group. aP < 0.05 vs. α-MHC(cTnI); bP < 0.05 vs. β-MHC(cTnI); cP < 0.05 vs. α-MHC(ssTnI).